Funding · Commerce & Consumer Brands

Be Clinical raises Rs 6 crore in extended seed

By Startup Enthusiast · 7 January 2026

What they do

Be Clinical is an evidence-led skincare brand offering clinically tested solutions for ageing skin, focusing on face, body, and scalp

The company raised Rs 6 crore in an extended seed round led by V3 Ventures, with participation from Titan Capital

Funds will boost R&D, in-house formulation, and manufacturing expansion, targeting India's gap in science-led anti-ageing products

Be Clinical raised Rs 6 crore in an extended seed round led by V3 Ventures.
Titan Capital, founded by Kunal Bahl and Rohit Bansal, participated in this tranche.
The round's earlier tranche of Rs 2 crore was led by Titan Capital, with Aditya Agarwal of P-TAL also investing.
Founder Hemangi Dhir launched the brand in May 2024.
The company will use the funds for R&D, in-house formulation, and clinical testing.
Plans include expanding the manufacturing facility with advanced machinery.
The company will also upgrade packaging to functional, protective, and premium formats.
Be Clinical has served over 25,000 customers since inception.

The brand addresses a market gap: a lack of science-led, transparent, clinically validated skincare solutions for Indian skin.
Its differentiation lies in in-vivo tested and clinically validated formulations, with end-to-end in-house research and manufacturing.
The funding signals growing investor interest in evidence-based beauty brands in India.
Competitors include Olay, Neutrogena, Clinique, and Dr. Sheth in the anti-ageing segment.

Be Clinical is an evidence-led skincare brand focused on ageing concerns across face, body, and scalp.
Products include Neck Repair Skin Tightening Night Cream, PlumpX Serum, FirmX Serum, Blemish Balance Serum, and SmoothX Hand Cream.
Prices range from Rs 999 to Rs 2,998.
The company offers free shipping on orders over Rs 100.
Clinical trials are registered on the Clinical Trial Registry of India.
Customer reviews mention visible improvement and suitability for sensitive skin.
The brand operates with an end-to-end in-house research and manufacturing model.

Product: Skincare products focused on ageing-related concerns, with plans to broaden into body and haircare.
Customers: Indian consumers looking for solutions for ageing skin.
How it makes money: It sells directly to consumers through a D2C skincare brand.
What sets it apart: Uses clinically tested, dermatologically active formulations designed for Indian skin and conditions.
Operations: Plans to strengthen R&D, clinical testing, and manufacturing, and to enter new markets.